A system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury
Mitsue Hibino(Hokkaido University), Yuma Yamada(Hokkaido University), Hideyoshi Harashima(Hokkaido University), Manabu Tokeshi(Hokkaido University), Yoichi Ishitsuka(Kumamoto University), Masatoshi Maeki(Japan Science and Technology Agency)
Cited by 24
Related Papers
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
|Biological and Pharmaceutical Bulletin|2013|479
Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
|Advanced Drug Delivery Reviews|2008|254
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|Advanced Drug Delivery Reviews|2020|123
Challenges in Promoting Mitochondrial Transplantation Therapy
|International Journal of Molecular Sciences|2020|106
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver
|Journal of Controlled Release|2015|97